These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 36454405)

  • 1. Long-term stability of 24 synthetic cannabinoid metabolites spiked into whole blood and urine for up to 168 days, and the comparable study for the 6 metabolites in non-spiked real case specimens stored for  1-5 years.
    Minakata K; Hasegawa K; Nozawa H; Yamagishi I; Miyoshi N; Suzuki M; Kitamoto T; Kondo M; Watanabe K; Suzuki O
    Forensic Toxicol; 2022 Jul; 40(2):289-301. PubMed ID: 36454405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative urine confirmatory testing for synthetic cannabinoids in randomly collected urine specimens.
    Castaneto MS; Scheidweiler KB; Gandhi A; Wohlfarth A; Klette KL; Martin TM; Huestis MA
    Drug Test Anal; 2015 Jun; 7(6):483-93. PubMed ID: 25231213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitive quantification of BB-22 and its metabolite BB-22 3-carboxyindole, and characterization of new metabolites in authentic urine and/or serum specimens obtained from three individuals by LC-QTRAP-MS/MS and high-resolution LC-Orbitrap-MS/MS.
    Minakata K; Hasegawa K; Nozawa H; Yamagishi I; Saitoh T; Yoshino A; Suzuki M; Kitamoto T; Suzuki O; Watanabe K
    Forensic Toxicol; 2019; 37(1):164-173. PubMed ID: 30636985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short- and long-term stability of synthetic cathinones and dihydro-metabolites in human urine samples.
    Aldubayyan AA; Castrignanò E; Elliott S; Abbate V
    Forensic Toxicol; 2024 Jul; 42(2):172-180. PubMed ID: 38554217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary prevalence, metabolite detection rates, temporal patterns and evaluation of suitable LC-MS/MS targets to document synthetic cannabinoid intake in US military urine specimens.
    Wohlfarth A; Scheidweiler KB; Castaneto M; Gandhi AS; Desrosiers NA; Klette KL; Martin TM; Huestis MA
    Clin Chem Lab Med; 2015 Feb; 53(3):423-34. PubMed ID: 25263309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stability of Synthetic Cannabinoids in Biological Specimens: Analysis Through Liquid Chromatography Tandem Mass Spectrometry.
    Fort C; Jourdan T; Jesse Kemp ; Curtis B
    J Anal Toxicol; 2017 Jun; 41(5):360-366. PubMed ID: 28334817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo detection of the new psychoactive substance AM-694 and its metabolites.
    Bertol E; Vaiano F; Di Milia MG; Mari F
    Forensic Sci Int; 2015 Nov; 256():21-7. PubMed ID: 26295909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimization of recombinant β-glucuronidase hydrolysis and quantification of eight urinary cannabinoids and metabolites by liquid chromatography tandem mass spectrometry.
    Sempio C; Scheidweiler KB; Barnes AJ; Huestis MA
    Drug Test Anal; 2018 Mar; 10(3):518-529. PubMed ID: 28815938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolism of Nine Synthetic Cannabinoid Receptor Agonists Encountered in Clinical Casework: Major in vivo Phase I Metabolites of AM-694, AM-2201, JWH-007, JWH-019, JWH-203, JWH-307, MAM-2201, UR-144 and XLR-11 in Human Urine Using LC-MS/MS.
    Hutter M; Broecker S; Kneisel S; Franz F; Brandt SD; Auwarter V
    Curr Pharm Biotechnol; 2018; 19(2):144-162. PubMed ID: 29745330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Excretion of metabolites of the synthetic cannabinoid JWH-018 in urine after controlled inhalation.
    Toennes SW; Geraths A; Pogoda W; Paulke A; Wunder C; Theunissen EL; Ramaekers JG
    J Pharm Biomed Anal; 2018 Feb; 150():162-168. PubMed ID: 29245085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liquid chromatography-tandem mass spectrometry screening method using information-dependent acquisition of enhanced product ion mass spectra for synthetic cannabinoids including metabolites in urine.
    Staeheli SN; Veloso VP; Bovens M; Bissig C; Kraemer T; Poetzsch M
    Drug Test Anal; 2019 Sep; 11(9):1369-1376. PubMed ID: 31219237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the long-term stability of select phenylacetylindole, cycloalkylindole, quinolinyl, and carboxamide synthetic cannabinoids using LC-MS-MS.
    Phung E; Lee D; Swart C; Ke Y; Moore-Bollinger K; Bynum N; Grabenauer M; Botch-Jones S
    J Anal Toxicol; 2023 Nov; 47(8):685-693. PubMed ID: 37697731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solid-phase extraction-liquid chromatography-tandem mass spectrometry method for the qualitative analysis of 61 synthetic cannabinoid metabolites in urine.
    Gaunitz F; Kieliba T; Thevis M; Mercer-Chalmers-Bender K
    Drug Test Anal; 2020 Jan; 12(1):27-40. PubMed ID: 31412168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In Vivo Metabolites of AB-PINACA in Solid Tissues Obtained from Its Abuser: Comparison with In Vitro Experiment.
    Minakata K; Hasegawa K; Yamagishi I; Nozawa H; Suzuki M; Kitamoto T; Suzuki O; Watanabe K
    J Anal Toxicol; 2021 Jan; 44(9):1027-1035. PubMed ID: 32232365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biotransformation of the New Synthetic Cannabinoid with an Alkene, MDMB-4en-PINACA, by Human Hepatocytes, Human Liver Microsomes, and Human Urine and Blood.
    Watanabe S; Vikingsson S; Åstrand A; Gréen H; Kronstrand R
    AAPS J; 2019 Dec; 22(1):13. PubMed ID: 31848852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantification of olanzapine and its three metabolites by liquid chromatography-tandem mass spectrometry in human body fluids obtained from four deceased, and confirmation of the reduction from olanzapine N-oxide to olanzapine in whole blood in vitro.
    Nozawa H; Minakata K; Hasegawa K; Yamagishi I; Miyoshi N; Suzuki M; Kitamoto T; Kondo M; Watanabe K; Suzuki O
    Forensic Toxicol; 2023 Jul; 41(2):318-328. PubMed ID: 36997675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nontargeted SWATH acquisition for identifying 47 synthetic cannabinoid metabolites in human urine by liquid chromatography-high-resolution tandem mass spectrometry.
    Scheidweiler KB; Jarvis MJ; Huestis MA
    Anal Bioanal Chem; 2015 Jan; 407(3):883-97. PubMed ID: 25224637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection and quantification of 5F-ADB and its methyl ester hydrolysis metabolite in fatal intoxication cases by liquid chromatography-high resolution mass spectrometry.
    Yeter O; Erol Öztürk Y
    Forensic Sci Int; 2019 Sep; 302():109866. PubMed ID: 31302415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LC/ESI-MS/MS method for quantification of 28 synthetic cannabinoids in neat oral fluid and its application to preliminary studies on their detection windows.
    Kneisel S; Speck M; Moosmann B; Corneillie TM; Butlin NG; Auwärter V
    Anal Bioanal Chem; 2013 May; 405(14):4691-706. PubMed ID: 23535743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Synthetic Cannabinoid Metabolites in Human Blood in the Absence of Parent Compounds: A Stability Assessment.
    Krotulski AJ; Bishop-Freeman SC; Mohr ALA; Logan BK
    J Anal Toxicol; 2021 Feb; 45(1):60-68. PubMed ID: 32435808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.